True North Advisors, LLC Gilead Sciences, Inc. Transaction History

True North Advisors, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $491,996 - $536,778	-6,654 Reduced 49.49%	6,791 $508,000
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $506,758 - $578,028	-6,667 Reduced 33.15%	13,445 $1.04 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $152,687 - $173,958	-1,975 Reduced 8.94%	20,112 $1.67 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $123,082 - $176,703	1,975 Added 9.82%	22,087 $1.9 Million
Q2 2022 Jul 28, 2022	SELL	$57.72 - $65.01 $5,194 - $5,850	-90 Reduced 0.45%	20,112 $1.24 Million
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $2.31 Million - $2.9 Million	-39,944 Reduced 66.41%	20,202 $1.2 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $493,347 - $559,958	7,604 Added 14.47%	60,146 $4.37 Million
Q3 2021 Jun 07, 2022	BUY	$67.69 - $73.03 $1,692 - $1,825	25 Added 0.05%	52,542 $3.67 Million
Q4 2020 May 20, 2022	SELL	$56.65 - $64.55 $170,686 - $194,489	-3,013 Reduced 5.43%	52,517 $3.06 Million
Q3 2020 May 20, 2022	SELL	$62.1 - $78.08 $4.97 Million - $6.25 Million	-79,985 Reduced 59.02%	55,530 $3.51 Million
Q2 2020 May 20, 2022	BUY	$72.34 - $84.0 $321,406 - $373,212	4,443 Added 3.39%	135,515 $10.4 Million
Q1 2020 May 12, 2022	BUY	$62.63 - $80.22 $1,691 - $2,165	27 Added 0.02%	131,072 $9.8 Million
Q4 2019 May 12, 2022	BUY	$61.62 - $67.78 $8.07 Million - $8.88 Million	131,045 New	131,045 $8.52 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of True North Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on True North Advisors, LLC with notifications on news.